+61480015851
Healthcare: EGFR Tyrosine Kinase Inhibitor - Cancer - Iressa - Portfolio Writing Assessment Answer
Download Solution
Order New Solution
Internal Code: 1AGEDH
Healthcare Assessment Answer
Assignment Task: Students to prepare a portfolio outlining a plan for the development of a particular compound (app. 1500 words). The portfolio will be presented in class with a final ppt presentation of max 15 minutes Cancer: Iressa / Gefitinib (EGFR tyrosine kinase inhibitor)- Design a monitoring sheet for monitoring of adverse effects in laboratory animals. Discuss the features of the monitoring sheet and how this relates to particular adverse effects that may be related to your drug class.
- Outline a strategy to protect your IP. Monitor your competition, avoid infringement of existing patents.
This Healthcare Assessment has been solved by our Nursing experts at onlineassignmentbank. Our Assignment Writing Experts are efficient to provide a fresh solution to this question. We are serving more than 10000+ Students in Australia, UK & US by helping them to score HD in their academics. Our Experts are well trained to follow all marking rubrics & referencing style.